医学
诱导疗法
内科学
克罗恩病
维持疗法
疾病
化疗
作者
Edward V. Loftus,Julián Panés,Ana P. Lacerda,Laurent Peyrin‐Biroulet,Geert D’Haens,Remo Panaccione,Walter Reinisch,Édouard Louis,Minhu Chen,Hiroshi Nakase,Jakob Begun,Brigid S. Boland,Charles D. Phillips,Mohamed‐Eslam F. Mohamed,Jianzhong Liu,Ziqian Geng,Feng Tian,Elena Dubcenco,Jean‐Frédéric Colombel
标识
DOI：10.1056/nejmoa2212728
摘要
Upadacitinib induction and maintenance treatment was superior to placebo in patients with moderate-to-severe Crohn's disease. (Funded by AbbVie; U-EXCEL, U-EXCEED, and U-ENDURE ClinicalTrials.gov numbers, NCT03345849, NCT03345836, and NCT03345823.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
张欢馨
Criminology34
GingerF
cdercder
学术孤儿
实验室
ansteel
可靠铸海
lili
OK
aajhajkahna
迪西
梁静茹给我的勇气
aubusson
渡人舟
东方元语
YifanWang
斯文的白玉
Nexus
初景
皖公网安备34019202002308
